Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C

Gastroenterology

Volumn 118, Issue 2, 2000, Pages 346-355

  Cramp, Matthew E ^a   Rossol, Siegbert ^c   Chokshi, Shilpa ^a,b   Carucci, Patrizia ^a   Williams, Roger ^a,b   Naoumov, Nikolai V ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Department of Gastroenterology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; GAMMA INTERFERON; HEPATITIS C ANTIGEN; INTERLEUKIN 10; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HEPATITIS C; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0033960092     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70217-4     Document Type: Article

References (36)

1. AM. Di Bisceglie Hepatitis C Lancet 351 1998 351 355
2. JH Hoofnagle AM. Di Bisceglie The treatment of chronic viral hepatitis N Engl J Med 336 1997 347 356
3. T Poynard P Marcellin SS Lee C Niederau GS Minuk G Ideo V Bain J Heathcote S Zeuzem C Trepo J. Albrecht Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Lancet 352 1998 1426 1432
4. JG McHutchison SC Gordon ER Schiff ML Shiffman WM Lee VK Rustgi ZD Goodman M-H Ling S Cort JK. Albrecht Interferon alfa2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 339 1998 1485 1492
5. M. Peters Actions of cytokines on the immune response and viral interactions: an overview Hepatology 23 1996 909 916
6. O Reichard ZB Yun A Sonnerborg O. Weiland Hepatitis C viral RNA titers in serum prior to, during and after oral treatment with ribavirin for chronic hepatitis C J Med Virol 41 1993 99 102
7. AM Di Bisceglie HS Conjeevaram MW Fried R Sallie Y Park C Yurdaydin M Swain DE Kleiner K Mahaney JH. Hoofnagle Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial Ann Intern Med 123 1995 897 903
8. G Dusheiko J Main H Thomas O Reichard C Lee A Dhillon S Rassam A Fryden H Reesink M Bassendine G Norkrans T Cuypers N Lelie P Telfer J Watson C Weegink P Sillikens O. Weiland Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study J Hepatol 25 1996 591 598
9. HCJ Bodenheimer KL Lindsay GL Davis JH Lewis SN Thung LB. Seeff Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial Hepatology 26 1997 473 477
10. HM Diepolder R Zachoval RM Hoffmann EA Wierenga T Santantonio MC Jung D Eichenlaub GR. Pape Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 1995 1006 1007
11. G Missale R Bertoni V Lamonaca A Valli M Massari C Mori MG Rumi M Houghton F Fiaccadori C. Ferrari Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J Clin Invest 98 1996 706 714
12. ME Cramp P Carucci S Rossol S Choksi G Maertens R Williams NV. Naoumov Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia Gut 44 1999 424 429
13. P Botarelli MR Brunetto MA Minutello P Calvo D Unutmaz AJ Weiner QL Choo JR Shuster G Kuo F Bonino M Houghton S. Abrignani T-lymphocyte response to hepatitis C virus in different clinical courses of infection Gastroenterology 104 1993 580 587
14. RM Hoffmann HM Diepolder R Zachoval FM Zwiebel MC Jung S Scholz H Nitschko G Riethmuller GR. Pape Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection Hepatology 21 1995 632 638
15. G Missale E Cariani V Lamonaca A Ravaggi A Rossini R Bertoni M Houghton Y Matsuura T Miyamura F Fiaccadori C. Ferrari Effects of interferon treatment on the anti-viral T-cell response in hepatitis C virus genotype 1b- and 2c-infected patients Hepatology 26 1997 792 797
16. J Lasarte M Garcia-Granero A Lopez N Casares N Garcia M Civeira F Borras-Cuesta J. Prieto Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C Hepatology 28 1998 815 822
17. G Marinos F Torre S Chokshi M Hussain BE Clarke DJ Rowlands AL Eddleston NV Naoumov R. Williams Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus Hepatology 22 1995 1040 1049
18. S Rossol R Voth HP Laubenstein WEG Muller HC Schroder KH Meyer zum Buschenfelde G. Hess Interferon production in patients infected with HIV-1 J Infect Dis 159 1989 815 821
19. SL Tsai Y-F Liaw M-H Chen C-Y Huang GC. Kuo Detection of type-2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity Hepatology 25 1997 449 458
20. A Neumann N Lam H Dahari D Gretch T Wiley T Layden A. Perelson Hepatitis C viral dynamics in-vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107
21. N Lam A Neumann D Gretch T Wiley A Perelson T. Layden Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 26 1997 226 231
22. S Zeuzem JM Schmidt JH Lee M von Wagner G Teuber WK. Roth Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover Hepatology 28 1998 245 252
23. S Zeuzem JH Lee A Franke B Ruster O Prummer G Herrmann WK. Roth Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa Hepatology 27 1998 1149 1156
24. FC Bekkering JT Brower SW Schalm A. Elewaut Hepatitis C: viral kinetics Hepatology 26 1997 1691 1693 (letter)
25. G Leroux Roels CA Esquivel R DeLeys L Stuyver A Elewaut J Philippe I Desombere J Paradijs G. Maertens Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa Hepatology 23 1996 8 16
26. MJ Koziel D Dudley N Afdhal QL Choo M Houghton R Ralston BD. Walker Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV J Virol 67 1993 7522 7532
27. DK Wong DD Dudley NH Afdhal J Dienstag CM Rice L Wang M Houghton BD Walker MJ. Koziel Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection J Immunol 160 1998 1479 1488
28. D Nelson C Marousis T Ohno G Davis J. Lau Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C Hepatology 28 1998 225 230
29. GL Davis R Esteban-Mur V Rustgi J Hoefs SC Gordon C Trepo ML Schifman S Zeusem A Craxi M-H Ling J. Albrecht Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C N Engl J Med 339 1998 1493 1499
30. C Hultgren D Milich O Weiland M. Sallberg The anti-viral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses J Gen Virol 79 1998 2381 2391
31. R Tam B Pai J Bard J Lim D Averett U Phan T. Milovanivic Ribavirin polarises human T cell responses towards a Th1 cytokine profile J Hepatol 39 1999 376 382
32. Q Ning D Brown J Parodo M Cattral R Gorczynski E Cole L Fung J Ding M Liu O Rotstein M Phillips G. Levy Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinases and preserves Th1 cytokine production but inhibits Th2 cytokine response J Immunol 160 1998 3487 3493
33. J Martin S Navas J Quiroga M Pardo V. Carreno Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients Cytokine 10 1998 635 644
34. W Heagy C Crumpacker P Lopez R. Finberg Inhibition of immune functions by anti-viral drugs J Clin Invest 87 1991 1916 1924
35. B Rocha A Grandien AA. Freitas Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance J Exp Med 181 1995 993 1003
36. AJ Zajac JN Blattman K Murali-Krishna DJ Sourdive M Suresh JD Altman R. Ahmed Viral immune evasion due to persistence of activated T cells without effector function J Exp Med 188 1998 2205 2213